Richard F Horan, MD - Medicare Allergy/immunology in Chestnut Hill, MA

Richard F Horan, MD is a medicare enrolled "Dermatology" physician in Chestnut Hill, Massachusetts. He went to Harvard Medical School and graduated in 1980 and has 44 years of diverse experience with area of expertise as Allergy/immunology. He is a member of the group practice Brigham And Women's Physicians Organization Inc, Atrius Health Inc, Dermatology Associates Pc and his current practice location is 850 Boylston St, Rhumatology Immunology And Allergy Suite 540, Chestnut Hill, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (617) 732-9850.

Richard F Horan is licensed to practice in Massachusetts (license number 54618) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1164412383.

Contact Information

Richard F Horan, MD
850 Boylston St, Rhumatology Immunology And Allergy Suite 540,
Chestnut Hill, MA 02467-2477
(617) 732-9850
Not Available



Physician's Profile

Full NameRichard F Horan
GenderMale
SpecialityAllergy/immunology
Experience44 Years
Location850 Boylston St, Chestnut Hill, Massachusetts
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Richard F Horan attended and graduated from Harvard Medical School in 1980
  NPI Data:
  • NPI Number: 1164412383
  • Provider Enumeration Date: 10/27/2005
  • Last Update Date: 01/03/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 6204882574
  • Enrollment ID: I20050330000122

Medical Identifiers

Medical identifiers for Richard F Horan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1164412383NPI-NPPES
3010198MedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology 54618 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Brigham And Women's HospitalBoston, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Brigham And Women's Physicians Organization Inc38704059882510
Atrius Health Inc47895886411116
Dermatology Associates Pc701298204416

News Archive

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

Analyzing proteins in blister fluid may classify burn severity more accurately

Severe burns can leave physical and psychological scars, especially in children. When a burn patient enters the clinic, doctors use factors such as the depth and size of the burn, as well as the time required for skin healing-or re-epithelialization-to determine the best course of treatment.

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear - a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Alcon board approves merger agreement with Novartis

Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Richard F Horan allows following entities to bill medicare on his behalf.
Entity NameAtrius Health Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871639914
PECOS PAC ID: 4789588641
Enrollment ID: O20031121000582

News Archive

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

Analyzing proteins in blister fluid may classify burn severity more accurately

Severe burns can leave physical and psychological scars, especially in children. When a burn patient enters the clinic, doctors use factors such as the depth and size of the burn, as well as the time required for skin healing-or re-epithelialization-to determine the best course of treatment.

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear - a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Alcon board approves merger agreement with Novartis

Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.

Read more Medical News

› Verified 5 days ago

Entity NameInternal Medicine Physicians Of The North Shore
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851498166
PECOS PAC ID: 5193798635
Enrollment ID: O20040813000759

News Archive

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

Analyzing proteins in blister fluid may classify burn severity more accurately

Severe burns can leave physical and psychological scars, especially in children. When a burn patient enters the clinic, doctors use factors such as the depth and size of the burn, as well as the time required for skin healing-or re-epithelialization-to determine the best course of treatment.

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear - a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Alcon board approves merger agreement with Novartis

Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.

Read more Medical News

› Verified 5 days ago

Entity NameDermatology Associates Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063570075
PECOS PAC ID: 7012982044
Enrollment ID: O20040901000673

News Archive

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

Analyzing proteins in blister fluid may classify burn severity more accurately

Severe burns can leave physical and psychological scars, especially in children. When a burn patient enters the clinic, doctors use factors such as the depth and size of the burn, as well as the time required for skin healing-or re-epithelialization-to determine the best course of treatment.

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear - a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Alcon board approves merger agreement with Novartis

Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.

Read more Medical News

› Verified 5 days ago

Entity NameDermatology & Skin Care Assoc Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003005331
PECOS PAC ID: 5193807899
Enrollment ID: O20080204000426

News Archive

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

Analyzing proteins in blister fluid may classify burn severity more accurately

Severe burns can leave physical and psychological scars, especially in children. When a burn patient enters the clinic, doctors use factors such as the depth and size of the burn, as well as the time required for skin healing-or re-epithelialization-to determine the best course of treatment.

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear - a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Alcon board approves merger agreement with Novartis

Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.

Read more Medical News

› Verified 5 days ago

Entity NameBrigham And Women's Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033535497
PECOS PAC ID: 3870405988
Enrollment ID: O20150107001260

News Archive

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

Analyzing proteins in blister fluid may classify burn severity more accurately

Severe burns can leave physical and psychological scars, especially in children. When a burn patient enters the clinic, doctors use factors such as the depth and size of the burn, as well as the time required for skin healing-or re-epithelialization-to determine the best course of treatment.

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear - a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Alcon board approves merger agreement with Novartis

Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard F Horan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Richard F Horan, MD
850 Boylston St, Ste 540,
Chestnut Hill, MA 02467-2477

Ph: (617) 732-9850
Richard F Horan, MD
850 Boylston St, Rhumatology Immunology And Allergy Suite 540,
Chestnut Hill, MA 02467-2477

Ph: (617) 732-9850

News Archive

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

Analyzing proteins in blister fluid may classify burn severity more accurately

Severe burns can leave physical and psychological scars, especially in children. When a burn patient enters the clinic, doctors use factors such as the depth and size of the burn, as well as the time required for skin healing-or re-epithelialization-to determine the best course of treatment.

Discovery offers promise for treatment of age-related hearing loss

Researchers have discovered that deletion of a specific gene permits the proliferation of new hair cells in the cochlea of the inner ear - a finding that offers promise for treatment of age-related hearing loss. This type of hearing loss is caused by aging, disease, certain drugs, and the cacophony of modern life. It is the most common cause of hearing loss in older people.

Researchers compare risk of target organ damage in masked versus sustained hypertension

In a new publication from Cardiovascular Innovations and Applications, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Alcon board approves merger agreement with Novartis

Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.

Read more News

› Verified 5 days ago


Dermatology Doctors in Chestnut Hill, MA

Thomas Eugene Rohrer, M.D.
Dermatology
Medicare: May Accept Medicare Assignments
Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467
Phone: 617-731-1600    Fax: 617-731-1601
Jeffrey Michael Sobell, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467
Phone: 617-731-1600    Fax: 617-731-1601
Prasanthi Kandula,
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1244 Boylston St, Chestnut Hill, MA 02467
Phone: 617-731-1600    
Kenneth Alfred Arndt, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467
Phone: 617-731-1600    Fax: 617-731-1601
Jeffrey Steven Dover, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467
Phone: 617-731-1600    Fax: 617-731-1601
Dr. Andrei Metelitsa, M.D., FRCPC
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 1244 Boylston St, Chestnut Hill, MA 02467
Phone: 617-731-1600    Fax: 617-731-1601

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.